Vetoquinol SA Overview
Pro stress-test →Vetoquinol is a France-based veterinary pharmaceutical company founded in 1933 that designs, develops, and sells veterinary drugs and non-medicinal products for livestock and companion animals across 100+ countries. The company reported €526 million in annual sales for 2025, with 70% from companion animals (dogs, cats) and 30% from livestock (cattle, pigs).
Strategic Profile
Pro stress-test →Vetoquinol operates as a diversified player in the global veterinary pharma market with products spanning pain/inflammation, antibiotics, anti-parasites, dermatology, cardiology, and behavior management. The company's geographic diversification—Europe 48.9%, North America 35.7%, Asia-Pacific 15.4%—and portfolio spanning 5 production sites globally provides operational resilience and market penetration advantages.
Competitive Landscape
Pro stress-test →Vetoquinol competes in the global veterinary pharmaceuticals market alongside larger players like Zoetis (dominant global competitor) and regional competitors. The market is characterized by consolidation, with Vetoquinol maintaining mid-market positioning through specialized therapeutic portfolios and geographic reach.
Industry Context
Vetoquinol SA operates in Veterinary Pharmaceuticals.
Key facts
Founded: 1933 · Headquarters: Lure, France · Employees: ~2,000 · Revenue: €526M (2025) · Market cap: €922M